Learning Collaborative #4 November 2015

Slides:

Advertisements

Similar presentations

Overview of HPV vaccination Training GardasilTM

Advertisements

HPV Vaccine Update Eileen Yamada, MD, MPH Immunization Branch California Department of Health Services.

You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Communicating about.

Improving adolescent immunization coverage Elyse O. Kharbanda, MD, MPH.

Tricia Washburn Rhode Island Department of Health Chief, Office of Immunization Rhode Island School Immunization Regulations.

Anticipated impact on HPV infection from HPV vaccination programs – cause for optimism Dr Paddy Horner.

Preventing HPV in the Mountain State

What's New on the Child and Adolescent Immunization Schedules William L. Atkinson, MD, MPH National Center for Immunization and Respiratory Diseases William.

Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.

TM 2011 Immunization Recommendations H. Cody Meissner, M.D. Professor of Pediatrics Tufts University School of Medicine Boston Floating Hospital for Children.

TM Prepared for your next patient. Review of Selected Changes to the 2012 Immunization Schedules H. Cody Meissner, MD Floating Hospital for Children Tufts.

The Facts About Gardasil By Andrew Coldrick. The advert 9Fbishttp:// 9Fbis.

ADOLESCENT IMMUNIZATIONS

HPV Related Disease Ginny Ryan. What Is HPV? The human papillomavirus is the most common sexually transmitted infection in the U.S. – 79 million Americans.

Kansas HPV Vaccination Project Kansas Association of Local Health Departments, Board Meeting 4/21/2015.

Better Health. No Hassles. Get Immunized! National Immunization Month.

Herpes Papillomavirus (HPV) and Varicella-zoster Virus (VZV) Vaccination Ellen Barbouche, MD Primary Care Conference 18 April 2007.

Exam #2 F 3/30 in WCH Review Th 3/29 at 5pm in GRG 102 Homework #3 is due 4/11. Bonus #2 is due W 4/4. Bonus #3 is due F 4/27.

The New HPV Vaccine Laura Zakowski, MD No conflicts of interest.

IMPROVING IMMUNIZATION RATES. LEARNING OBJECTIVES Enhance understanding of benefits of a recall system for adolescent immunizations and well checks. Increase.

National Immunization Partnership with the APA: A Quality Improvement Project Specific to HPV Vaccination (NIPA) CDC Grant # 1H23IP

Barren River District Health Department Human Papillomavirus (HPV)

National Immunization Partnership with the Academic Pediatric Association (NIPA) CDC Grant # 1H23IP

Troi Cunningham, RN Kentucky Immunization Program October 2015.

The Second Cancer Vaccine: Human Papillomavirus Vaccine Meg Fisher, MD Medical Director.

Bee Wise Immunize Governor’s Child Health Advisory Committee Immunization Workgroup Topeka, KS November 19, 2010 Sue Bowden, RN, BS Director, KDHE Immunization.

National Immunization Partnership with the Academic Pediatric Association (NIPA) CDC Grant # 1H23IP

GARDASIL Vaccination HEALTH PROMOTION PROJECT BRANDI MALSY DECEMBER 3, 2014.

Partnering with FQHCs and CHCs to Increase HPV Vaccination Molly Black | Associate Director, HPV Vaccination | American Cancer Society Jane Harris | Health.

HPV and Pap Guidelines Jennifer Johnson MD. Objectives 1. Define the new PAP guidelines. 2. Identify the historical trends and new evidence resulting.

National Immunization Partnership with the Academic Pediatric Association (NIPA) CDC Grant # 1H23IP

 The Breast and Cervical Cancer Control Program N.C. Cancer Prevention and Control Branch Brittney M. Sala, BS, MPHN Candidate.

National Immunization Partnership with the APA: A Quality Improvement Project Specific to HPV Vaccination (NIPA) Wave 2 CDC Grant # 1H23IP

Dacy Gaston NSG  According to the CDC (2014)  “Human papillomavirus (pap-ah-LO-mah-VYE-rus) (HPV) is the most common sexually transmitted virus.

The Effects of a Media Campaign on Human Papillomavirus Vaccine Coverage Rates in Alaska Lyndsey “Sarah” Mixson Public Health Associate Office for State,

Welcome to the Immunization Requirements Webinar for Clinic Staff! For technical difficulties, call , press 1. During this webinar, everyone.

Children’s Outcomes Research Program The Children’s Hospital Aurora, CO Children’s Outcomes Research Program The Children’s Hospital Aurora, CO Colorado.

Update on HPV vaccines and recommendations - Lauri Markowitz Plans for monitoring impact of HPV vaccine - Eileen Dunne Uptake of HPV vaccine, ISS Sentinel.

National Immunization Partnership with the Academic Pediatric Association (NIPA) CDC Grant # 1H23IP

You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Successfully Communicating.

Learning Collaborative #1 March 2017

QUALITY IMPROVEMENT FOR HPV VACCINATION

HPV Vaccine is Cancer Prevention

Final Learning Collaborative November/December 2016

Making Effective HPV Vaccine Recommendations

Learning Collaborative #5 September 2016

Khaled Janom Ambulatory report

You are the Key to HPV Cancer Prevention

© I.M.Quizitor Pediatrics Date.

Principles of HPV vaccination Some derived from Phase III trials Some are based on clinical judgement / research HPV vaccines have no contraindications.

Human Papillomavirus Kenneth McCall, BSPharm, PharmD, BCGP

HPV Vaccination Recommendation Update: 2 doses or 3?

HPV Vaccines and Data Needed for Development of Recommendations in the United States Lauri E. Markowitz, MD Centers for Disease Control and Prevention.

Human Papillomavirus (HPV)

HPV VACCINES Dr. Kirtan Krishna.

10 Things You Should Know About HPV

World Health Organization

What’s New in Adult Immunization

Improving Immunization Rates in Clatsop County:

World Health Organization

Effective HPV Vaccine Recommendations

World Health Organization

10 Things You Should Know About HPV

Learning Collaborative #6 October 2016

HPV AFIX Site Visits: Overview

Martha A. Wojtowycz, PhD March 22, 2019

Research Update: The HPV Vaccines

World Health Organization

World Health Organization

Presentation transcript:

Learning Collaborative #4 November 2015 National Immunization Partnership with the Academic Pediatric Association (NIPA) CDC Grant # 1H23IP000950

Agenda Take attendance (5 min) HPV9 (5 min) Review of site questions/concerns with HPV9 (10 min) Review of site progress with their strategies (30 min) Questions (8 min) Next month – reminder (2 min)

9 -Valent HPV Vaccine 9-valent HPV vaccine targets HPV 16, 18, 31, 33, 45, 52, 58 plus 6, 11 These types account for 66% (16,18)+ 15% of cervical cancers (total 81%) and 90% of genital warts 14% of cancers in females, 4% in males caused by the additional 5 types CIN 2+ lesions 50% attributable to HPV 16/18 25% attributable to 5 additional types

9-valent HPV vaccine Efficacy: 97% vs. CIN2, VIN2/3 Higher antibody titers in 9-15 compared to 16-26 yr olds Safe to use concomitantly with MenACWY and Tdap Slightly higher injection site reaction than HPV4

Recommendations 3-dose schedule 0, 1-2 months, 6 months No need to restart if interrupted Can use any HPV vaccine product to complete the series No recommendation for those who previously completed the series HPV9 vaccine recommendations are the SAME as for HPV4 vaccine and these vaccines can and should be used interchangeably

HPV9 vaccine vs HPV4 vaccine Should you target HPV9 vaccine to females (added cancer benefit) and use up HPV4 in males? There is increased HPV oncogenic strain protection for females. The key is effective delivery of HPV vaccine to all adolescents. Be careful if you contemplate this. Do not disrupt your delivery system for all adolescents with added complexity of decision rules for administration.

Questions? How is 9-valent HPV vaccine delivery going in your practice? Any issues with transitioning?

Site Progress on QI Strategies How is each site progressing with their strategies? (Prompts, Standing Orders, Reminder-Recall) Any questions?

Learning Collaborative #5 December 2015 *holiday schedule Tues 12/15 @ 8am ET/ 7am CT/ 6am MT/ 5am PT Tues 12/15 @ Noon ET/ 11am CT/ 10am MT/ 9am PT Wed 12/16 @ 3pm ET/ 2pm CT/ 1pm MT/ Noon PT

Contact Information Please contact: Nui Dhepyasuwan, MEd Phone: 703/556 9222 x103 I Fax: 703/556 8729 Email: nui@academicpeds.org Holly Tyrrell, MSSW Phone: 703/556 9222 x113 I Fax: 703/556 8729 Email: hollyce@academicpeds.org